Latest News about NVO
Recent news which mentions NVO
   Pfizer Just Confirmed It's a Dividend Investor's Dream Stock
   
  
  
  August 01, 2024
  From Motley Fool
 From Motley Fool
 
   The Top 7 Stocks to Buy Now: Summer 2024
   
  
  
  July 31, 2024
  From InvestorPlace
 From Benzinga
 From Benzinga
 
   Novo Nordisk's Ozempic Reduces Smoking-Related Health Interventions In Diabetic Patients, Study Finds
   
  
  
  July 30, 2024
  From Benzinga
 
   DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
   
  
  
  July 30, 2024
  From Motley Fool
 
   3 Overlooked Stocks Poised for a Breakout Very Soon
   
  
  
  July 29, 2024
  From InvestorPlace
 From Motley Fool
 From Motley Fool
 From Motley Fool
 Tickers 
   NVO
  
  
  From Motley Fool
 
   Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?
   
  
  
  July 27, 2024
  From Motley Fool
 From Motley Fool
 
   Novo Nordisk Shares Decline Amid Competitive Pressure
   
  
  
  July 25, 2024
  From Benzinga
 
   Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
   
  
  
  July 25, 2024
  From Benzinga
 From InvestorPlace
 
   Beware, Wegovy -- Pfizer Is Working on a Competitor
   
  
  
  July 25, 2024
  From Motley Fool
 
   3 Fabulous Growth Stocks to Buy and Hold Forever
   
  
  
  July 24, 2024
  From InvestorPlace
 
   UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages
   
  
  
  July 24, 2024
  From Benzinga
 
   Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
   
  
  
  July 24, 2024
  From Benzinga
 From InvestorPlace
 
   Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
   
  
  
  July 23, 2024
  From Benzinga
 
   Britain's Drug Regulator Approves Novo Nordisk's Weight Loss Drug Wegovy To Cut Heart Disease Risk In Obese Patients
   
  
  
  July 23, 2024
  From Benzinga
 
   Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
   
  
  
  July 23, 2024
  From Motley Fool
 
   Why Hims & Hers Heath Shares Are Surging Today
   
  
  
  July 22, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

